Bicocca Open Archive

Logo unimib boa
BOMBELLI, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.637
AS - Asia 9.948
EU - Europa 7.394
SA - Sud America 1.434
AF - Africa 246
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 15
Totale 35.691
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.666
SG - Singapore 3.937
CN - Cina 2.067
IT - Italia 1.520
HK - Hong Kong 1.299
RU - Federazione Russa 1.237
DE - Germania 1.184
VN - Vietnam 1.147
BR - Brasile 1.056
SE - Svezia 859
CA - Canada 830
IE - Irlanda 719
UA - Ucraina 452
GB - Regno Unito 399
FR - Francia 319
IN - India 301
BD - Bangladesh 213
FI - Finlandia 201
KR - Corea 167
AR - Argentina 142
TR - Turchia 106
IQ - Iraq 104
ID - Indonesia 103
NL - Olanda 85
ZA - Sudafrica 85
ES - Italia 77
MX - Messico 76
PL - Polonia 70
PK - Pakistan 69
EC - Ecuador 60
AT - Austria 58
JP - Giappone 58
CO - Colombia 56
PH - Filippine 52
SA - Arabia Saudita 51
DK - Danimarca 49
UZ - Uzbekistan 48
VE - Venezuela 36
CL - Cile 32
MA - Marocco 27
EG - Egitto 25
CZ - Repubblica Ceca 24
KE - Kenya 24
MY - Malesia 21
BE - Belgio 20
AZ - Azerbaigian 19
IR - Iran 18
JO - Giordania 18
PY - Paraguay 18
RO - Romania 18
AE - Emirati Arabi Uniti 16
PE - Perù 16
AU - Australia 15
LB - Libano 15
TN - Tunisia 15
ET - Etiopia 14
LT - Lituania 14
AL - Albania 13
JM - Giamaica 13
TH - Thailandia 13
CH - Svizzera 12
IL - Israele 12
TW - Taiwan 12
DZ - Algeria 11
EU - Europa 11
UY - Uruguay 11
KZ - Kazakistan 10
NP - Nepal 10
OM - Oman 10
PA - Panama 10
BG - Bulgaria 9
TT - Trinidad e Tobago 9
BH - Bahrain 8
DO - Repubblica Dominicana 8
PT - Portogallo 8
HN - Honduras 7
PS - Palestinian Territory 7
SN - Senegal 7
BO - Bolivia 6
GR - Grecia 6
HU - Ungheria 6
KH - Cambogia 6
LK - Sri Lanka 6
LV - Lettonia 6
BY - Bielorussia 5
CI - Costa d'Avorio 5
EE - Estonia 5
SY - Repubblica araba siriana 5
BB - Barbados 4
CR - Costa Rica 4
GE - Georgia 4
GT - Guatemala 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
BJ - Benin 3
LA - Repubblica Popolare Democratica del Laos 3
LY - Libia 3
NI - Nicaragua 3
QA - Qatar 3
Totale 35.636
Salva come PNG Salva come JPEG
Città #
Singapore 2.087
Ann Arbor 1.953
Ashburn 1.490
San Jose 1.304
Hong Kong 1.288
Woodbridge 944
Fairfield 824
Houston 783
Frankfurt am Main 732
Chandler 709
Dublin 679
Toronto 623
Wilmington 490
New York 484
Jacksonville 467
Dearborn 435
Milan 396
Seattle 379
Santa Clara 360
Beijing 359
Ho Chi Minh City 316
Hanoi 295
Hefei 294
Chicago 286
Cambridge 268
Los Angeles 257
Dallas 247
Princeton 244
Boardman 177
The Dalles 164
Seoul 158
Lauterbourg 138
Nanjing 130
Moscow 126
Shanghai 123
Altamura 122
Lawrence 117
Buffalo 107
São Paulo 93
Council Bluffs 91
Munich 90
Lachine 80
San Diego 77
Helsinki 76
Orem 76
Guangzhou 62
London 56
Da Nang 55
Rome 54
Nanchang 52
Haiphong 51
Warsaw 51
Jakarta 50
Baghdad 49
Andover 43
Montreal 42
Tokyo 42
Tashkent 40
Brooklyn 39
Chennai 38
Dong Ket 38
Fremont 38
Johannesburg 38
Tianjin 38
Rio de Janeiro 37
Atlanta 36
Hebei 36
Nuremberg 34
Salt Lake City 34
Shenyang 34
Vienna 33
Columbus 31
Denver 31
Falls Church 31
Lissone 31
Turku 29
Changsha 28
Phoenix 28
Manchester 27
Amsterdam 26
Dhaka 26
Monza 25
Ottawa 25
Mumbai 24
Stockholm 24
Jiaxing 22
Kunming 22
New Delhi 22
Poplar 22
Jinan 21
Ningbo 21
Quito 21
Belo Horizonte 20
Nürnberg 20
Zhengzhou 20
Porto Alegre 19
Brno 18
Buenos Aires 18
Elk Grove Village 18
Nairobi 18
Totale 22.746
Salva come PNG Salva come JPEG
Nome #
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 485
Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid 407
Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage 363
Differing associations for sport versus occupational physical activity and cardiovascular risk 357
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 355
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 333
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 332
Gender-related differences in serum uric acid in treated hypertensive patients fromcentral and east European countries: Findings from the blood pressure control rate and cardiovascular risk profile study 331
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 322
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 320
The Pamela study: main findings and perspectives 309
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 305
Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people 301
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 298
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 296
Vitamin B12 deficiency-induced pseudothrombotic microangiopathy without macrocytosis presenting with acute renal failure: a case report 294
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 294
Prevalence and clinical significance of a greater ambulatory versus office blood pressure ('reversed white coat' condition) in a general population 290
HYPERTENSIVE EMERGENCIES AND URGENCIES: ADHERENCE TO GUIDELIENS AND RELATIONSHIP BETWEEN BLOOD PRESSURE MANAGEMENT AND IN-HOSPITAL MORTALITY 288
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 288
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study 284
Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study) 281
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 276
Normal values of left-ventricular mass: echocardiographic findings from the PAMELA study 273
Impact of demographic, anthropometric, haemodynamic factors on left atrial size in the general population: data from the PAMELA study 273
Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events 271
Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension 270
Neuroadrenergic disarray in pseudo-resistant and resistant hypertension 270
Combined effects of hypertension and hypercholesterolemia on radial artery function 269
New-onset left atrial enlargement in a general population 269
Accuracy evaluation of the 'Cardiette BP one' ambulatory blood pressure monitor 268
Role of ambulatory blood pressure monitoring in resistant hypertension 268
The association between 24-h blood pressure patterns and left ventricular mechanics 266
Relationships between residual blood pressure variability and cognitive function in the general population of the PAMELA study 265
Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure 264
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 264
Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population 263
Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population 263
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 263
Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study 263
High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population 261
Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population 260
Blood pressure variability and organ damage in a general population: Results from the PAMELA study 260
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study 259
Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients 255
Comparison of the new alpha 1-blocker alfuzosin with propranolol as first-line therapy in hypertension 253
IMPORTANCE OF URIC ACID THRESHOLD IN ITS CORRELATION WITH METABOLIC SYNDROME 251
Multicentre randomised, double blind, evaluation of nebivolol plus HCTZ and irbesartan plus HCTZ in the treatment of systolic hypertension in the elderly: the NEHIS Study 250
Blood pressure (clinic, home, 24-h) profiles and clinical correlates in 248
C68 RESTING HEART RATE AND ARTERIAL STIFFNESS: A LONGITUDINAL PROSPECTIVE STUDY IN A POPULATION OF HYPERTENSIVE PATIENTS 247
Simultaneous validation of the SunTech 247 diagnostic station blood pressure measurement device according to the British hypertension society protocol, the international protocol and the association for the advancement of medical instrumentation standards 247
Different neuroadrenergic activation and baroreflex function in resistant and pseudoresistant hypertension: a microneurographic study 246
Risk of mortality in relation to an updated classification of left ventricular geometric abnormalities in a general population: The PAMELA Study 246
Diurnal blood pressure variation and sympathetic activity 242
Limited reproducibility of MUCH and WUCH: Evidence from the ELSA study 242
Clinic, home, 24-hour blood pressure profiles and clinical correlates in resistant hypertension: data from the PAMELA Study 241
HIV and metabolic syndrome - A comparison with the general population 239
Should white-coat hypertension in diabetes be treated? Pro 239
Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: Data from the PAMELA population 239
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 237
Importance of uric acid threshold in its correlation with metabolic syndrome 237
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 236
Impact of body mass index and waist circumference on the cardiovascular risk and all-cause death in a general population: Data from the PAMELA study 236
Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: The PAMELA study 236
The Pamela Study: Old and New Findings 234
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 233
The PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni) study: Main features and results 232
Prognostic value of "partial" and "true" white coat hypertension: data from 16 year follow-up in the PAMELA population 232
Triglyceride-glucose Index and Mortality in a Large Regional-based Italian Database (Urrah Project) 231
Neurological hypertensive emergencies: Correlation of blood pressure values with in-hospital outcomes in ischemic stroke 230
Predictive value of different indices of blood pressure variability on 230
Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension 229
Uric Acid and New Onset Left Ventricular Hypertrophy: Findings From the PAMELA Population 228
Resting Heart Rate and Arterial Stiffness: a Longitudinal Prospective Study in a Population of Hypertensive Patients 227
Impact of body mass index and waist circumference on the long-term risk of diabetes mellitus, hypertension, and cardiac organ damage 223
Long-term risk of sustained hypertension in white-coat or masked hypertension 222
Comparison of electrocardiographic versus echocardiographic detection of left ventricular mass changes over time and evaluation of new onset left ventricular hypertrophy 221
Metabolic Syndrome is Related to Vascular Structural Alterations But Not to Functional one both in Hypertensives and Healthy Subjects in Selected abstracts from the XXXVIII National Congress of the Italian Society of Hypertension (SIIA) 221
Long-term prognistic value of white-coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements 221
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 221
4C.07:Relationships between cognitive dysfunction, clinic and ambulatory blood pressure and blood pressure variability: results from the PAMELA Study 220
Incidence and risk factors for delayed intracranial hemorrhage after mild brain injury in anticoagulated patients: a multicenter retrospective study 218
Novel Antihypertensive Therapies: Renal Sympathetic Nerve Ablation and Carotid Baroreceptor Stimulation 216
Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation? 216
Long-term increase in serum uric acid and its predictors over a 25 year follow-up: Results of the PAMELA study 211
Aortic root diameter and risk of cardiovascular events in a general population: data from the PAMELA study 211
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population: The PAMELA study 210
Metabolic syndrome is related to vascular structural alterations but not to functional ones both in hypertensives and healthy subjects 210
Aortic root diameter and risk of cardiovascular events in a general population: the PAMELA study 209
Diagnosis and management of patients with white-coat and masked hypertension 208
Bloodstream infections due to multi-drug resistant bacteria in the emergency department: prevalence, risk factors and outcomes—a retrospective observational study 207
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives 206
Do reverse dippers have the highest risk of right ventricular remodeling? 206
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 205
Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis 205
Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study 204
Williams syndrome is associated with an increase in heart rate and wave reflection values during the nighttime period. 204
Association between ADRA1A gene and the metabolic syndrome: Candidate genes and functional counterpart in the PAMELA population 202
Nighttime Blood Pressure and New-Onset Left Ventricular Hypertrophy: Findings From the Pamela Population 200
Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: Results of the CROSS study 199
Totale 25.660
Salva come PNG Salva come JPEG
Categoria #
all - tutte 123.960
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.960
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021203 0 0 0 0 0 0 0 0 0 0 0 203
2021/20221.706 109 159 172 182 148 144 63 76 104 114 129 306
2022/20233.123 312 901 277 258 214 468 53 207 183 56 114 80
2023/20242.396 62 71 104 123 298 598 457 91 232 43 35 282
2024/20256.152 319 718 285 281 476 170 269 274 570 858 737 1.195
2025/202613.948 1.463 858 1.083 1.505 1.539 703 2.148 605 1.130 1.328 1.010 576
Totale 36.343